Results 221 to 230 of about 61,865 (283)

Widespread influence of artificial light at night on ecosystem metabolism. [PDF]

Nat Clim Chang
Johnston ASA, Kim J, Harris JA.
europepmc   +1 more source

ISUOG Consensus Statement on sonographic assessment of the endometrium: how to perform a gynecological ultrasound scan and report the findings

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 2, Page 241-258, February 2026.
T.  Van den Bosch, R.  Heremans, C.  Landolfo, E.  Epstein, F. P. G.  Leone, T.  Bourne, D. Timmerman, Collaborators, J. Preisler, O. Rotenberg, H. Marret, G. Condous, J. L. Alcázar, D. Fischerová, U. Metzger, C. Van Pachterbeke, D. Franchi, M. Nisolle, J. Huirne, C. Fotopoulou, S. Goldstein   +20 more
wiley   +1 more source

Exploring the Relationship Between Obesity, Weight Loss and Health‐Related Quality of Life: An Updated Systematic Review of Reviews

Clinical Obesity, Volume 16, Issue 1, February 2026.
ABSTRACT The aim of this systematic literature review (SLR) of reviews was to update the evidence, established in a 2017 SLR, on the impact of obesity and weight loss by various interventions on health‐related quality of life (HRQoL). In total, eight SLRs and/or meta‐analyses published since 2017 were identified. The results consistently demonstrated a
Tone Nygaard Flølo, Hui‐Hsuan Liu, John Roger Andersen, Ronette L. Kolotkin   +3 more
wiley   +1 more source

Soil Microbes Mediate Productivity Differences Between Natural and Plantation Forests. [PDF]

Plants (Basel)
Zhang X, Yang M, Liu Y, Ye J, Tangyu J, Gao J, Liu W, Fan Y.   +7 more
europepmc   +1 more source

Baseline characteristics in the SYNCHRONIZE™‐2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP‐1 receptor dual agonist, for obesity in people with type 2 diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1490-1498, February 2026.
Abstract Aims Survodutide is an investigational glucagon receptor/glucagon‐like peptide‐1 receptor dual agonist that has shown promise for treating obesity and its complications in Phase 2 trials. Two double‐blind, randomized, global Phase 3 trials are designed to assess the efficacy and safety of survodutide for treatment of obesity—SYNCHRONIZE™‐1 in ...
Sean Wharton, Carel W. le Roux, Biykem Bozkurt, Elke Platz, Gabriele Bleckert, Samina Ajaz Hussain, Martina Brueckmann, Elena Startseva, Isabel M. Kloer, Lee M. Kaplan   +9 more
wiley   +1 more source

Acute methotrexate-induced cutaneous ulceration in generalized pustular psoriasis: A case report and review of the literature. [PDF]

JAAD Case Rep
Aljabri M, Assaedi L, Alqahtani S, Al-Osaimi A, Radin A, Ahmed W.   +5 more
europepmc   +1 more source

Assessment of thyroid cancer risk associated with glucagon‐like peptide 1 receptor agonist use

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1499-1507, February 2026.
Abstract Aims Published literature has raised concerns regarding a causal association between glucagon‐like peptide 1 receptor agonist (GLP‐1RA) use and thyroid cancer risk in adults. In this analysis, we evaluated the association between thyroid cancer risk and GLP‐1RA use.
Tina Vilsbøll, Michael Stellfeld, Vanita R. Aroda, Sune Dandanell, Jens‐Peter David, Ceyda T. P. Kristiansen, Søren Rasmussen, Fiona L. Roberts, Laszlo Hegedüs   +8 more
wiley   +1 more source

Considerations for Treating Generalized Pustular Psoriasis (GPP): A Narrative Review. [PDF]

Dermatol Ther (Heidelb)
Lynde CW, Prajapati VH, Gooderham MJ, Hong HC, Kirchhof MG, Lansang P, Ringuet J, Turchin I, Vender R, Yeung J, Papp KA.   +10 more
europepmc   +1 more source

PIONEER REAL Saudi Arabia: A multicentre, prospective, real‐world study of once‐daily oral semaglutide use in adults with type 2 diabetes in Saudi Arabia

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1304-1314, February 2026.
Abstract Aim PIONEER REAL Saudi Arabia investigated real‐world clinical outcomes associated with the use of once‐daily oral semaglutide in adults with type 2 diabetes (T2D). Materials and Methods This was a 34‐ to 44‐week multicentre, prospective, open‐label study in adults with T2D, who were treatment‐naive to injectable glucose‐lowering medication ...
Hussein ElBadawi, Nader Albalkhi, Ibrahim Al Kadhim, Ahmed Elsadig, Dimitrios Baltzis, Mohamed Hassan Hatahet, Mahmoud Ismail, Said Khader, Christina Louise Rasmussen, Stine Hedegaard Scheuer, Ahmed Shalaby, Mohammed Almehthel   +11 more
wiley   +1 more source

Is apparent optimum soil moisture equivalent to field capacity? [PDF]

Nat Commun
Zhao Y, Hu Q, Suo L, Wang Y, Hunt A.
europepmc   +1 more source